Gastrointestinal Agents Market by Type, Disease Type, Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030- Product Image

Sale

Gastrointestinal Agents Market by Type, Disease Type, Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030

Report
185 Pages
October 2024
Region: Global
360iResearch™
ID: 5977939

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Gastrointestinal Agents Market grew from USD 57.26 billion in 2023 to USD 60.06 billion in 2024. It is expected to continue growing at a CAGR of 4.97%, reaching USD 80.47 billion by 2030.

The market scope for gastrointestinal agents includes a comprehensive range of products designed to manage and treat various gastrointestinal disorders, such as antacids, proton pump inhibitors, H2 blockers, laxatives, and antiemetics. These agents are crucial in healthcare due to the rising prevalence of conditions like gastroesophageal reflux disease (GERD), peptic ulcers, irritable bowel syndrome (IBS), and chronic constipation. They are widely applied in both prescription and over-the-counter formats, serving diverse end-users such as hospitals, clinics, and retail pharmacies. Market growth is powerfully influenced by factors such as an aging global population more prone to digestive issues, increasing awareness, and enhanced access to medical treatments. The surge in lifestyle-related ailments due to poor dietary habits and stress is amplifying demand, while technological advancements in drug delivery systems represent fresh avenues and opportunities for development. Innovations in personalized medicine and precision dosing can significantly impact therapeutic outcomes, making them promising areas for research and development. However, the market faces limitations such as side effects related to long-term drug use, regulatory constraints, and the high cost associated with advanced treatments. Additionally, stiff competition from generic drug manufacturers poses economic challenges to branded pharmaceuticals. Companies can capitalize on growth by adopting strategies focused on R&D for novel drug formulations, exploring partnerships to enhance distribution networks, and investing in educational marketing campaigns to boost patient adherence to treatment regimens. Navigating the regulatory landscape and addressing unmet clinical needs through innovative therapeutics could further create significant opportunities in this evolving market. Although competitive, the gastrointestinal agents market offers substantial potential for businesses that prioritize sustainable, patient-centric solutions and adapt swiftly to industry dynamics.

Understanding Market Dynamics in the Gastrointestinal Agents Market

The Gastrointestinal Agents Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing prevalence of gastrointestinal disorders across the globe
- Educational campaigns about gastrointestinal health and available treatments
- Favorable changes in health insurance coverage and reimbursement policies
Market Restraints
- Disruptions in the supply of raw materials required for drug manufacturing
Market Opportunities
- Government approvals for new therapeutic agents to treat gastrointestinal disorders
- Ongoing research and development aimed at innovative drug formulations and delivery systems
Market Challenges
- Side effects associated with gastrointestinal drugs and supplements

Exploring Porter’s Five Forces for the Gastrointestinal Agents Market

Porter’s Five Forces framework further strengthens the insights of the Gastrointestinal Agents Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Gastrointestinal Agents Market

External macro-environmental factors deeply influence the performance of the Gastrointestinal Agents Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Gastrointestinal Agents Market

The Gastrointestinal Agents Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gastrointestinal Agents Market

The Gastrointestinal Agents Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Gastrointestinal Agents Market

The Gastrointestinal Agents Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Agents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Health, Amway Corporation, Archer-Daniels-Midland Company, ARKOPHARMA Laboratories, Company Limited, Bayer AG, Biomedical Research Laboratories, LLC, DuPont de Nemours, Inc., Dymatize Enterprises LLC, FANCL Corporation, Glanbia PLC, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Himalaya Wellness Company, Nature’s Sunshine Products, Inc., Nestlé S.A, Nutraceutical International Corporation, NutraScience Labs, Otsuka Holdings Co. Ltd., Pfizer Inc., Pragati Biocare Pvt. Ltd.,, Procter & Gamble Health Limited, Pure Encapsulations, LLC., Sabinsa Corporation, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Dietary Supplements
- Drugs
  - Antacids
  - Anti-diarrheal Agents
  - Anti-emetics
  - H2 Blockers
  - Laxatives
  - Proton Pump Inhibitors
Disease Type
- Constipation
- Diarrhea
- Gastroesophageal Reflux Disease
- Inflammatory Bowel Disease
- Irritable Bowel Syndrome
- Peptic Ulcer Disease
Route of Administration
- Oral
- Parenteral
- Rectal
Distribution Channel
- Offline Pharmacies
- Online Pharmacies
End-User
- Homecare
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of gastrointestinal disorders across the globe
5.1.1.2. Educational campaigns about gastrointestinal health and available treatments
5.1.1.3. Favorable changes in health insurance coverage and reimbursement policies
5.1.2. Restraints
5.1.2.1. Disruptions in the supply of raw materials required for drug manufacturing
5.1.3. Opportunities
5.1.3.1. Government approvals for new therapeutic agents to treat gastrointestinal disorders
5.1.3.2. Ongoing research and development aimed at innovative drug formulations and delivery systems
5.1.4. Challenges
5.1.4.1. Side effects associated with gastrointestinal drugs and supplements
5.2. Market Segmentation Analysis
5.2.1. Type: Growing usage of dietary supplements with an increasing number of health-conscious consumers
5.2.2. End-User: High potential of gastrointestinal agents across hospitals & clinics as part of initial treatment and ongoing management plans for patients
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Gastrointestinal Agents Market, by Type

6.1. Introduction
6.2. Dietary Supplements
6.3. Drugs
6.3.1. Antacids
6.3.2. Anti-diarrheal Agents
6.3.3. Anti-emetics
6.3.4. H2 Blockers
6.3.5. Laxatives
6.3.6. Proton Pump Inhibitors

7. Gastrointestinal Agents Market, by Disease Type

7.1. Introduction
7.2. Constipation
7.3. Diarrhea
7.4. Gastroesophageal Reflux Disease
7.5. Inflammatory Bowel Disease
7.6. Irritable Bowel Syndrome
7.7. Peptic Ulcer Disease

8. Gastrointestinal Agents Market, by Route of Administration

8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Rectal

9. Gastrointestinal Agents Market, by Distribution Channel

9.1. Introduction
9.2. Offline Pharmacies
9.3. Online Pharmacies

10. Gastrointestinal Agents Market, by End-User

10.1. Introduction
10.2. Homecare
10.3. Hospitals & Clinics

11. Americas Gastrointestinal Agents Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Gastrointestinal Agents Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Gastrointestinal Agents Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Introduction of Calm & Focus: A Zembrin and GABA-Based Dietary Supplement by PLT Health Solutions
14.3.2. Innovative Women’s Health Probiotics Launched by Designs for Health
14.3.3. Market Introduction of Wonderbelly Antacid with Exclusive Flavor at Target Stores
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. GASTROINTESTINAL AGENTS MARKET RESEARCH PROCESS
FIGURE 2. GASTROINTESTINAL AGENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. GASTROINTESTINAL AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GASTROINTESTINAL AGENTS MARKET DYNAMICS
TABLE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-DIARRHEAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-EMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 55. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 56. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 87. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 88. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 93. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 106. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 142. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 161. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. FINLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 179. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. FRANCE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. GERMANY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 196. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 197. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. ITALY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. NORWAY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 220. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 221. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. POLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. QATAR GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 251. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SPAIN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 269. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. TURKEY GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 285. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Gastrointestinal Agents market, which are profiled in this report, include:

Abbott Laboratories
American Health
Amway Corporation
Archer-Daniels-Midland Company
ARKOPHARMA Laboratories, Company Limited
Bayer AG
Biomedical Research Laboratories, LLC
DuPont de Nemours, Inc.
Dymatize Enterprises LLC
FANCL Corporation
Glanbia PLC
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
Himalaya Wellness Company
Nature’s Sunshine Products, Inc.
Nestlé S.A
Nutraceutical International Corporation
NutraScience Labs
Otsuka Holdings Co. Ltd.
Pfizer Inc.
Pragati Biocare Pvt. Ltd.,
Procter & Gamble Health Limited
Pure Encapsulations, LLC.
Sabinsa Corporation
Sanofi S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 60.06 Billion
Forecasted Market Value ( USD ) by 2030	$ 80.47 Billion
Compound Annual Growth Rate	4.9%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Gastrointestinal Agents Market

Exploring Porter’s Five Forces for the Gastrointestinal Agents Market

Applying PESTLE Analysis to the Gastrointestinal Agents Market

Analyzing Market Share in the Gastrointestinal Agents Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gastrointestinal Agents Market

Strategic Recommendations for Success in the Gastrointestinal Agents Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Gastrointestinal Bleeding Treatment Devices Market by Product Type, Treatment Type, End User - Global Forecast 2025-2030

Gastrointestinal Drugs Market by Drug Category, Disease Type, Route of Administration, End User - Global Forecast 2025-2030

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2024-2032

Gastrointestinal Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

Gastrointestinal Drugs Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

About the Gastrointestinal Agent Market